Objectives
Principal Investigators
 . Gerard Cangelosi
 . Patrick Duffy
 . Jean Feagin
 . Michal Fried
 . Malcolm Gardner
 . Nancy Haigwood
 . Helen Horton
 . Stefan Kappe
 . Peter Myler
 . Marilyn Parsons
 . David Sherman
 . Arnold Smith
 . Joseph Smith
 . Don Sodora
 . Leonidas Stamatatos
 . Ken Stuart
 . Ruobing Wang
 . Theodore White
Senior Scientists
Staff Scientists
Collaborations
Core Technologies

   
 

. Biography

. Publications

. Staff

. Links


Joseph D. Smith, Ph.D.

Associate Member
Seattle Biomedical Research Institute
Associate Director, Malaria Program

Email: joseph.smith@sbri.org
Disease under study: Malaria

Mission
As part of the global initiative to fight malaria, SBRI is using innovative strategies and advanced technologies to investigate the malaria parasite. Launched by a $5 million grant from the Bill & Melinda Gates foundation, SBRI recruited malaria scientists and initiated a combination of research and clinical studies towards the development of malaria vaccines.

Research
Dr. Smith’s research on Plasmodium falciparum seeks to understand the processes of antigenic variation and cytoadherence, key factors in parasite immune evasion and a virulence determinant for the parasite. During the blood stage development, P. falciparum parasites export cytoadhesive proteins to the infected erythrocyte surface that allow infected erythrocytes to sequester from blood circulation. This process allows parasites to avoid spleen-dependent killing mechanisms, but can lead to severe disease complications when infected erythrocytes accumulate in brain or placental blood vessels.

The parasite proteins involved in infected erythrocyte sequestration are called P. falciparum erythrocyte membrane protein 1 (PfEMP1). PfEMP1 proteins are encoded by approximately 60 var genes per parasite isolate, but are expressed in a mutually exclusive fashion. Switching between var genes allows the parasite to evade immune destruction and sequester at different sites in the body.

Dr. Smith’s lab is studying the binding properties and genetic diversity of PfEMP1 proteins, in order to develop interventions that can prevent malaria disease complications.

Themes
     * Cytoadherence of infected erythrocytes 
     * Pregnancy malaria 

Lab
Accomplishments
     * Developed binding assays and computational approaches to investigate the parasite cytoadherent receptors responsible for infected erythrocyte sequestration and disease.
     * Inter-isolante var gene comparisons and genome-wide binding comparisons.

*  

Characterized PfEMP1 protein involved in placental binding that is being developed as a vaccine for malaria during pregnancy.
   

Dr. Smith's current research is currently supported by the National Institutes of Health (NIH).

 

HOME | CONTACT US | SITEMAP | DONATE | POLICY

©2008 Seattle Biomedical Research Institute. All rights reserved.

SBRI is a 501(c)3 not-for-profit organization. info@sbri.org